We recently developed a two-step clonal cell culture system for murine lymphohematopoietic progenitors that are capable of producing myeloid and B-lymphoid progenies and characterized their cytokine requirements. We subsequently observed that addition of interleukin-3 (IL-3) or IL-la to permissive cytokine combinations in primary culture abrogates the B-lymphoid potential but not the myeloid potential of the lymphohematopoietic progenitors. We now describe a similar negative regulation of the T-cell potential of the lymphohematopoietic progenitors. Lin-Ly-GA/E+ marrow cells from 5-fluorouracil-treated mice were plated individually by micromanipulation in methylcellulose culture with steel factor (SF) and IL-l1 for 8 days. The resulting colonies ECENTLY, INVESTIGATORS IN THREE laboratories described cell culture assays for lymphohematopoietic progenitors that are capable of myeloid and B-lymphoid differentiation.'" Using the two-step clonal methylcellulose culture for murine lymphohematopoietic progenitor^,^ we have elucidated positive and negative cytokine regulation of early B-lymphopoiesis. We observed that combinations of steel factor (SF) and interleukin-6 (IL-6), IL-11, granulocyte colony-stimulating factor (G-CSF),3 or IL-1 24 support the proliferation of lymphohematopoietic progenitors with myeloid and B-lymphoid capabilities. More recently, we observed that the ligand for flt3/flk-2 (FL) also synergizes with IL-6, IL-11, or G-CSF in support of B-cell potential of the lymphohematopoietic progenitor^.^ Surprisingly, IL-3 could neither replace nor act synergistically with SF or FL in maintaining the B-lymphoid potential of the primary c~l o n i e s~,~; however, L 3 was as effective as SF6 and more effective than FL in support of myeloid colony f~rmation.~ In addition, IL-3 in concentrations as low as 0.1 n g h L caused over 95% inhibition of the B-cell potential of lymphohematopoietic progenitors when added to permissive cytokine combinations.' After screening known lymphohematopoietic cytokines, we found that IL-1 (both a and p) in low concentrations also suppress the B-lymphoid potential of the progenitors.' The strong inhibitory effects of IL-3 and IL-l on the B-lymphoid potential of the lymphohematopoietic progenitors prompted us to examine the effects of these cytokines on the T-cell potential of the lymphohematopoietic progenitors. The results of our studies indicate that IL-3 and IL-la also strongly suppress the T-cell potential of the lymphohematopoietic progenitors.
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R MATERIALS AND METHODS
Growth factors. Murine SF was provided by Kirin Brewery CO (Tokyo, Japan). Human IL-la was provided by Y. Hirai (Otsuka Pharmaceutical, Tokushima, Japan). Murine IL-3 was purchased from R & D Systems (Minneapolis, MN). Human IL-6 was a gift from M. Naruto (Toray Industries, Yokohama, Japan). Human IL-7 and IL-11 were gifts of C. Faltynek (Sterling Drug, Malvern, PA) and P. Schendel (Genetics Institute, Cambridge, MA), respectively. Erythropoietin (Epo) was provided by the Genetics Institute Clinical Manufacturing Group (Cambridge, MA). All cytokines we used were recombinant and purified, and their concentrations were as follows: were tested for myeloid potential by reculturing part of each colony in secondary myeloid suspension culture. Remainders of individual primary colonies were injected intravenously into scid mice for determination of T-and B-lymphoid potentials. Approximately 10% of the progenitors that differentiated along myeloid lineages in culture reconstituted Tand B-cell compartments in scid mice. However, when scid mice were injected with colonies pooled from cultures containing steel factor, IL-11, and either IL-3 or IL-lcu, there was no reconstitution of thymocytes or spleen T cells. These results suggest negative regulatory roles for IL-3 and IL-la in the early stages of T lymphopoiesis. 0 1995 by The American Society of Hematology.
SF, 20 ng/mL; L-la, 1.0 ng/mL; IL-3, 10 ng/mL; IL-6, 100 ng/ m L ; IL-7, 5 ng/mL; L-11, 100 ng/mL, and Epo, 2 U/mL.
Progenitor puriJication. Bone marrow (BM) cells were harvested from 10-to 16-week-old BDFl mice (Charles River, Raleigh, NC) that had been injected intravenously with 5-fluorouracil (5-FU; Adria Laboratories, Columbus, OH) at 150 mg/kg (body weight) 2 days before. The BM cells were enriched for progenitor cells using the technique we described previously.8 Briefly, cells at densities ranging from 1.0631 to 1.0770 g/mL were harvested with metrizamide (Accurate Chemical & Scientific, Westbury, NY) density centrifugation. The samples were then rendered devoid of cells expressing lineage-specific antigens by negative immunomagnetic bead selection with Dynabeads M-450 sheep antirat IgG (Dynal, Great Neck, NY). The monoclonal antibodies used were anti-B220 (14.8): antiMac-l (Ml/7O),Io anti-Gr-l (RB6-8C5),I1 anti-L3T4 (GKl.5),'* anti-Ly-2 (53-6.72),13 and TER-1 19.14 The density-separated, lineage-negative (Lin-) cells were then stained with fluorescein isothiocyanate (FITC)-conjugated anti-Ly-6-antibody (D7)I5 and sorted for Ly-6A/E+ cells using a FACStar Plus cell sorter (Becton Dickinson, San Jose, CA).
Clonal methylcellulose culture. Methylcellulose culture was performed using 35-mm suspension culture dishes (Becton Dickinson Labware, Lincoln Park, NJ). Enriched BM cells were individually plated by micrornanipulati~n~~'~ and were cultured in methylcellulose with SF and L-11 in the presence or the absence of IL-7. Enriched BM cells were also cultured (50 cells/dish) under three conditions, ie, in the presence of SF, IL-11, and IL-7: SF, IL-11, L-7, and IL-3: or SF, IL-I 1, IL-7, and IL-la. The culture medium consisted of amedium (Flow Laboratories, Rockville, MD), 1.2% 1500-centipoise methylcellulose (Shinetsu Chemical, Tokyo, Japan), 25% fetal calf serum (FCS; Intergen, Purchase, NY), 1% deionized fraction-V bovine serum albumin (BSA; Sigma, St Louis, MO), and 0.1 mmol/L 2-mercaptoethanol (2-ME; Sigma). Dishes were incubated at 37°C in a humidified atmosphere flushed with 5% CO2 for 8 days.
Analysis of lymphoid potentials of individual progenitors by in vivo transfer.
The enriched BM cells from BDFl mice (Ly-1.2/ 1. I , H-2Kh'd) were individually plated by use of micromanipulation into cultures containing SF and IL-I 1 with or without IL-7. On day 8 of culture, resulting primary colonies were individually picked, and 80% of cells in each colony were injected into individual 7-to IO-week-old female C.B.-17 scid mice (Ly-1.2, H-2Kd; Taconic Farms, Germantown, NY). Control mice did not receive injections.
Three months after the cell transfer, all mice were killed, and thymocytes were stained with anti-Ly-1.1 antibody (7-20.6/3, plus streptavidin-phycoerythrin. Based on isotype control and noninjected mice, the mice were considered reconstituted when donor-derived cells comprised more than 1% of thymocytes or spleen cells in the recipient mice.
Cell culture analysis of B-lymphoid and myeloid potential:, of progenitors. Ten percent of each primary colony was recultured with SF and IL-7 in methylcellulose medium containing 25% FCS, 1 % BSA, 0.1 m m o K 2-ME in 35-mm dishes for pre-B-cell colony formation.' On day 1 1 of the secondary culture, large compact unicentric colonies consisting of small round cells were counted as pre-B cell colonies as we reported before.' The remainder of cells of each primary colony were recultured in a 96-well plate in a-medium containing 25% FCS, 1% BSA, 0.1 mmol/L 2-ME, SF, 1L-l I , and Epo for examination of the myeloid potential of the primary colonies. After incubation for 5 days, cells were centrifuged onto a slide for cytological examination with May-Grunwald Giemsa.
In vivo transfer of pooled primary colonies. Fifty enriched BM cells were cultured with SF, IL-I 1, and IL-7 in the presence or the absence of IL-3 and IL-la. On day 8, 160 primary colonies were picked from each culture group and were pooled and washed. One eighth or one eightieth of the sample (equivalent to 20 or 2 colonies, respectively) was injected intravenously into each of four scid mice. Three to four months later, recipient mice were analyzed for donorderived lymphocytes.
RESULTS

T-and B-lymphoid potentials of individual progenitors.
The T-and B-cell potentials of the progenitors were examined by in vivo transfer of the primary colonies into scid mice. To ensure clonal origin of the primary colonies, we plated individual progenitors by micromanipulation.''h LinLy-6AIE+ BM cells were cultured individually with SF plus IL-l1 or SF, IL-11, and IL-7, as shown in Table I ses, we presented percentages of donor-derived lymphocytes in individual recon-* Number of reconstituted mice per total number of mice injected. In parenthestituted mice. In all control noninjected mice and unreconstituted mice, the percentages of donor-haplotype lymphocytes were less than 1%. whereas about 60% of the spleen cells were donor-derived (H-2Kh'), 50% to 60% of which were CD3' and TCRaP' T cells (Figs 1F and G) . The remainder of the donor-derived cells in the spleen were IgM' B cells (Fig 1H) . In 1 mouse in Exp 2, only B cells, but neither thymocytes nor spleen Tcells, were reconstituted. No donor-derived cells were observed in control mice (Figs 1A through D) .
B-cell potential of the same progenitors was also assessed in culture by replating a part of individual primary colony into secondary methylcellulose culture containing SF and IL-7. Of 17 primary colonies examined in Exp 2, 6 gave rise t o pre-B-cell colonies in culture. These included the 3 colonies that showed B-cell potential through in vivo transfer. The primary colonies that reconstituted the B-cell compartment in scid mice tended to yield more pre-B -cell colonies ( l ,030, 170, and 20 pre-B-cell colonies per primary colony), than those that did not (60, 20, and 20 pre-B-cell colonies per primary colony), although the difference was not statistically significant. 
and Thy-1.2 (A and E), and spleen cells for H-2Kb and CD3 (B and F), H-2Kb and TCRa/3 (C and G), and H2Kb and IgM (D and H). Representative analysis of a control mouse with no injection (A through D) and a reconstituted mouse (E through H) are shown.
T-and B-lymphoid potentials of pooled primary colonies.
Because of the heterogeneity of the primary colonies and the low incidence (approximately 10%) of the lymphohematopoietic progenitors detectable through in vivo transfer, we pooled primary colonies and tested their T-cell potential. Fifty enriched BM cells were plated per dish in methylcellulose medium containing SF, IL-11, and IL-7. On day 8 of culture, 160 resulting colonies were individually picked and pooled, and one eighth of the pooled cells (equivalent to 20 primary colonies) were injected into 4 scid mice. The result of a representative experiment is shown in Table 1 . In all of the mice, thymocytes and spleen T cells as well as spleen B cells contained cells with donor markers.
Inhibitory effects of IL-3 and IL-la on the T-cell potential of the lymphohematopoietic progenitors. By using the in vivo transfer of pooled primary colonies, we next examined negative regulation of early T-lymphopoiesis. Enriched BM cells were cultured in methylcellulose (50 cellsldish) under three conditions, ie, SF, IL-11, and IL-7; SF, IL-11, IL-7, and L-3; SF, IL-11, IL-7, and L -l a . On day 8 of culture, 160 primary colonies were picked from each culture group and were pooled and washed. In a representative experiment, the number of total cells in each sample was 2.7 X lo6, 4.4 X lo6, and 2.2 X lo6, respectively. One eighth of the pooled cells (equivalent to 20 colonies) was injected into each of 4 scid mice. One eightieth of the pooled cells (equivalent to 2 colonies) from the cultures lacking IL-3 or IL-la were also injected. Four control mice did not receive injections. All mice were killed 3.5 months later, and thymocytes and spleen cells were analyzed for donor-derived cells. As summarized in Table 2 -1.2, H-2Kd ). Thymocytes were analyzed 3% months later for Ly-1.1 and Thy-1.2, and spleen cells were analyzed for H-2Kb, CD3, and TCRaB. * Number of reconstituted mice per total number of mice injected. In parentheses, we presented percentages of donor-derived lymphocytes in individual reconstituted mice. In all control noninjected mice and unreconstituted mice the percentage of donor-haplotype lymphocytes were less than 1%.
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thymocytes and spleen T-cells, and another mouse showed reconstitution of spleen T cells but not thymocytes ( Table  2) . When pooled colonies from the cultures containing either IL-3 or IL-la were injected, 20-colony equivalent cells reconstituted neither thymocytes nor spleen T cells ( Table 2 and Figs 2D through I) .
DISCUSSION
Earlier, we described development of a two-step methylcellulose culture assay for lymphohematopoietic progenitom3 In this culture, lymphohemopoietic progenitors were allowed to differentiate along myeloid and B-lymphoid lineages in the primary culture, and the presence of committed B-lymphoid progenitors in the primary colonies was detected by pre-B-cell colony formation in the secondary culture. We now report the presence of T-cell potential in the primary colonies based on studies using in vivo transfer of the primary colonies into scid mice. Our data indicated that the combination of SF and IL-l1 in the primary culture supports the differentiation of pluripotent lymphohematopoietic progenitors along T-lymphoid as well as myeloid and B-lymphoid lineages. IL-7 was dispensable in the primary culture. Approximately 10% of the colonies derived from progenitors in the BM of 5-fluorouracil-treated mice could differentiate into myeloid, B-cell, and T-cell lineages. In one experiment, B-cell potential of the same progenitors was also assessed using the two-step methylcellulose culture assay. Culture studies identified twice as many progenitors as having B-cell potential as those identified by in vivo transfer assay. The low incidence of the pluripotent lymphohematopoietic progenitors as identified by in vivo transfer assay may be due to the low sensitivity of this assay.
H-2Kb
Although some of the progenitors that responded to SF, IL-1 1, and IL-7 are pluripotent, the exact nature of these progenitors is unknown. In a preliminary observation:' cells expanded in response to similar combinations of cytokines for 2 weeks in suspension culture retained the ability to reconstitute hematopoiesis of lethally irradiated mice. However, the levels of engraftment were lower than those of the original cell population. In a series of studies we have shown that these cytokines can trigger cell proliferation of primitive progenitors in cell cycle dormant (Go) state." It appears that some stem cells in Go respond to SF, IL-11, and IL-7 to express multilineage potentials. Elucidation of the precise mechanisms of cytokine-stem cell interactions requires the availability of a purified population of stem cells.
Nor are we certain about the nature of the cells reconstituting T cells in the scid mice. Because committed B-cell progenitors develop in the primary culture from lymphohematopoietic progenitors: it is possible that committed T-cell progenitors also arise in the primary culture and reconstitute thymocytes and spleen T-cells on transplantation into scid mice. Recently, Rodewaid et alZ3 reported the presence of committed T-cell progenitors in fetal blood that lacks multipotent progenitor potential but retains the ability to 
